Ignite Creation Date:
2024-05-06 @ 7:14 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05947448
Status:
RECRUITING
Last Update Posted:
2024-04-01
First Post:
2023-07-07
Brief Title:
Efficacy and Safety of Mexartan Potassium Tablets AZL-M and Calcium Channel Blockers CCB in the Treatment of Adults With Essential Hypertension in Chinese Population a National Multicenter Prospective Observational Study
Sponsor:
Hasten Biopharmaceutical Co Ltd
Organization:
Hasten Biopharmaceutical Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-22
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-07
First Submit QC Date:
July 7 2023
Study First Post Date:
2023-07-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-28
Last Update Post Date:
2024-04-01
Last Update Post Date Type:
ACTUAL